Award recordCONTRACT

ACORDA THERAPEUTICS, INC.

PIID VA26016F9100· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6810 · CHEMICALS· FY2016· $339,033 net obligations· UEI R5D3FUPFFPK4· NY

Description

AMPYR 10-MG

First action · last action
2015-10-01 · 2016-06-09
Transactions
2
First transaction's obligation
$201,121
Base + all options value (sum of deltas)
$339,033
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5233B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$339,033$0Base award · 2015-10-01 · this action $201,121 · running total $201,121Modification P00001 · 2016-06-09 · this action $137,912 · running total $339,033
  • Base2015-10-01+$201,121= $201,121
  • Mod P000012016-06-09+$137,912= $339,033
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-10-01+$201,121$201,121AMPYR 10-MG
Mod P00001· FUNDING ONLY ACTION2016-06-09+$137,912$339,033AMPYR 10-MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI R5D3FUPFFPK4)

AwardOffice · PSC / listingNet obligationsFY
36C77024N0067NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$493,607FY2024
36E79724A0005NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C77024N0027NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$444,505FY2024
36F79723D0194NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36E79723A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C77023N0057NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$529,877FY2023

Other recipients under 6810 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26018P3900LIFE CHEMICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$80,976FY2018
VA26018P2530BSE PERFORMANCE, LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$24,960FY2018
VA26017F0129UNITED THERAPEUTICS CORP260-NETWORK CONTRACT OFFICE 20 (36C260)$91,147FY2017
VA26017J3080ARIAD PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$79,221FY2017
VA26016F1444LUNDBECK LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$6,829FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26016F9100_3600_V797P5233B_3600 · retrieved 2026-09-26.